Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study

scientific article

Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2016PLoSO..1154900Q
P356DOI10.1371/JOURNAL.PONE.0154900
P932PMC publication ID4858273
P698PubMed publication ID27148878
P5875ResearchGate publication ID301932523

P50authorEugenia Quiros-RoldanQ30650722
Elena RaffettiQ47710022
P2093author name stringFrancesco Donato
Francesco Castelli
Emanuele Focà
Chiara Pezzoli
Michele Magoni
Alice Ferraresi
Filippo Castelnuovo
Nigritella Brianese
P2860cites workHigh neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions.Q51555647
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.Q51943315
Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III.Q53074863
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and byQ55037836
2013 ACC/AHA Guideline on the Assessment of Cardiovascular RiskQ57413870
Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammationQ59450174
Hyperlipidemia-Triggered Neutrophilia Promotes Early AtherosclerosisQ63915146
Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery diseaseQ73155625
Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectorisQ74182408
An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities studyQ79873289
HIV infection and the risk of acute myocardial infarctionQ27347231
Statistical methods in cancer research. Volume II--The design and analysis of cohort studiesQ29615413
Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure.Q30301196
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) studyQ30934548
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs studyQ33602915
Low grade inflammation and coronary heart disease: prospective study and updated meta-analysesQ33910496
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatmentQ34315579
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studiesQ34469221
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rateQ34557258
Consolidated and emerging inflammatory markers in coronary artery diseaseQ35019922
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisQ35182277
HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarctionQ35636087
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study.Q36034748
Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapyQ37492492
C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task ForceQ37608837
Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter StudyQ39377412
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort studyQ40971969
Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severityQ41454338
Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary interventionQ43709336
Blood Neutrophil to Lymphocyte Ratio as a Predictor of HypertensionQ44884810
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectcardiovascular diseaseQ389735
P304page(s)e0154900
P577publication date2016-05-05
P1433published inPLOS OneQ564954
P1476titleNeutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study
P478volume11

Reverse relations

cites work (P2860)
Q88816367Association of Neutrophil-to-Lymphocyte Ratio With Mortality and Cardiovascular Disease in the Jackson Heart Study and Modification by the Duffy Antigen Variant
Q55512944Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: a multicenter retrospective cohort study from 2007 to 2015.
Q92696173Cardiovascular adverse events during treatment with darunavir-based regimens in an Italian observational study
Q59811129Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis
Q36309602Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort

Search more.